Discovery of potent anti-inflammatory flavonoid-sesquiterpenoid hybrids from Syzygium simile: Structure–activity relationships and nanomolar inhibition of human neutrophil activation
8 affiliations
- 1School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan
- 2Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
- 3Graduate Institute of Health Industry Technology and Center for Drug Research and Development, Chang Gung University of Science and Technology, Taoyuan, Taiwan
- 4Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, Chinese Medicine Research Center, China Medical University, Taichung, Taiwan
- 5Department of Biotechnology, Asia University, Taichung, Taiwan
- 6Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan
- 7Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan
- 8Department of Pharmacy, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan
Abstract
Context: Current anti-inflammatory drugs often cause significant adverse effects, underscoring the need for safer alternatives. Natural products with rare and distinctive scaffolds represent a promising source of leads for discovering new anti-inflammatory agents.
Objective: This study aimed to find anti-inflammatory flavonoid-sesquiterpenoid hybrids from Syzygium simile (Myrtaceae), and to clarify the structural-activity relationship underlying their inhibition of biomarkers in activated human neutrophils.
Materials and methods: A range of chromatographic techniques was sequentially applied to isolate pure compounds, the structures of which were elucidated by spectroscopic and spectrometric analyses. Anti-inflammatory activities were evaluated in fMLP/CB-induced human neutrophils by measuring inhibitory effects on superoxide anion generation and elastase release.
Results: Twenty-two flavonoid-sesquiterpenoid hybrids, including thirteen previously undescribed structures, were isolated from S. simile leaves, comprising five flavonoid scaffolds (types I–V) and five sesquiterpenoid moieties (germacrene-, cubebene-, oplopene-, cadinene-, and copaene-types) generated via distinctive electron transfer-mediated biosynthesis. Most compounds potently inhibited superoxide anion generation and elastase release, with IC50 values up to 32-fold lower than that of the positive control, without exhibiting cytotoxicity.
Discussion and Conclusion: Structure-activity relationship analysis revealed that the combination of a type I flavonoid and a germacrene-type sesquiterpenoid skeleton, integrated through an rA-type ring fusion, represents the optimal pharmacophore. The lead compound, simisyzygin C (3), achieved nanomolar potency with IC50 values of 0.04 μM (superoxide anion) and 0.16 μM (elastase release). These findings identify flavonoid-sesquiterpenoid hybrids as a structurally distinctive class of anti-inflammatory natural products, providing a structural basis for lead optimization.
Related
- 981 Tumor-mediated innate training of neutrophil progenitors involves FOXO1 activation and promotes immunotherapy-associated colitis
- Activation of α7 Nicotinic Acetylcholine Receptor Inhibits Neutrophil ex vivo Swarming and Pulmonary Recruitment in Inflamed Mice through an Integrin αMβ2-dependent Mechanism
- Anti-inflammatory macrophages limit endothelial inflammation and restrict neutrophil recruitment through Gas6/AXL signaling
- Tissue factor-associated neutrophil extracellular traps in dermatomyositis: procoagulant activity and endothelial activation in vitro
- Pharmacologically altered androgens, brain activation and response inhibition in a stop-signal task in male heavy drinkers
BibTeX
@article{lin2026discovery,
title = {{Discovery of potent anti-inflammatory flavonoid-sesquiterpenoid hybrids from Syzygium simile: Structure–activity relationships and nanomolar inhibition of human neutrophil activation}},
author = {Yu-Chun Lin and Ho-Cheng Wu and Tsong-Long Hwang and Yueh-Hsiung Kuo and Chu-Hung Lin and Horng-Huey Ko and Hsun-Shuo Chang},
journal = {Pharmaceutical Biology},
year = {2026},
month = oct,
doi = {10.1080/13880209.2026.2746239},
url = {https://doi.org/10.1080/13880209.2026.2746239},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Discovery of potent anti-inflammatory flavonoid-sesquiterpenoid hybrids from Syzygium simile: Structure–activity relationships and nanomolar inhibition of human neutrophil activation
AU - Yu-Chun Lin
AU - Ho-Cheng Wu
AU - Tsong-Long Hwang
AU - Yueh-Hsiung Kuo
AU - Chu-Hung Lin
AU - Horng-Huey Ko
AU - Hsun-Shuo Chang
PY - 2026
DA - 2026/10/28
JO - Pharmaceutical Biology
DO - 10.1080/13880209.2026.2746239
UR - https://doi.org/10.1080/13880209.2026.2746239
AB - Context: Current anti-inflammatory drugs often cause significant adverse effects, underscoring the need for safer alternatives. Natural products with rare and distinctive scaffolds represent a promising source of leads for discovering new anti-inflammatory agents. Objective: This study aimed to find anti-inflammatory flavonoid-sesquiterpenoid hybrids from Syzygium simile (Myrtaceae), and to clarify the structural-activity relationship underlying their inhibition of biomarkers in activated human neutrophils. Materials and methods: A range of chromatographic techniques was sequentially applied to isolate pure compounds, the structures of which were elucidated by spectroscopic and spectrometric analyses. Anti-inflammatory activities were evaluated in fMLP/CB-induced human neutrophils by measuring inhibitory effects on superoxide anion generation and elastase release. Results: Twenty-two flavonoid-sesquiterpenoid hybrids, including thirteen previously undescribed structures, were isolated from S. simile leaves, comprising five flavonoid scaffolds (types I–V) and five sesquiterpenoid moieties (germacrene-, cubebene-, oplopene-, cadinene-, and copaene-types) generated via distinctive electron transfer-mediated biosynthesis. Most compounds potently inhibited superoxide anion generation and elastase release, with IC50 values up to 32-fold lower than that of the positive control, without exhibiting cytotoxicity. Discussion and Conclusion: Structure-activity relationship analysis revealed that the combination of a type I flavonoid and a germacrene-type sesquiterpenoid skeleton, integrated through an rA-type ring fusion, represents the optimal pharmacophore. The lead compound, simisyzygin C (3), achieved nanomolar potency with IC50 values of 0.04 μM (superoxide anion) and 0.16 μM (elastase release). These findings identify flavonoid-sesquiterpenoid hybrids as a structurally distinctive class of anti-inflammatory natural products, providing a structural basis for lead optimization.
SN - 1388-0209
SN - 1744-5116
ER -